Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-10-19

Clinical Trial Update: A Drug Interaction Study Between Simvastatin and GSK376501 [Phase 1]

View source ↗

Summary

A Phase 1 study assessed the potential interaction between simvastatin and the investigational GSK376501; the trial in Type 2 Diabetes Mellitus completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GSK376501
  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED